|
New research in animals suggests why the commonly prescribed cholesterol-lowering drug ezetimibe (ZetiaŽ) is so potent. The research, reported by scientists at Wake Forest University School of Medicine, is reported online by the Journal of Clinical I |
|
The first and only over-the-counter product for weight loss approved by the Food and Drug Administration was available from Friday, June 15.
|
|
Experts from the University of Granada (Universidad de Granada) carried out research on atherosclerosis from its earliest stages to discover the origin of atheromatous plaques - fatty deposits gradually and irregularly formed in the main arteries, causin |
|
A new Cholesterol Guidelines Report by the Policy Analysis Centre, launched today at the European Atherosclerosis Society (EAS) meeting in Helsinki, Finland, shows that more needs to be done to improve implementation of the Third European Joint Taskforce |
|
INEGY™ (ezetimibe/simvastatin) was significantly more effective at influencing coronary heart disease (CHD) risk factors than Lipitor (atorvastatin) in type 2 diabetes patients with hypercholesterolemia according to results of two analyses presente |
|
INEGY™ (ezetimibe/simvastatin) allowed significantly more patients with hypercholesterolemia than Crestor™(rosuvastatin) to achieve study specified levels ("Goals") for both Low Density Lipoprotein ("bad") cholesterol (LDL-C) and each one of |
|
Statins are safe, well tolerated, and have a proven impact on cardiovascular disease, concludes the author of a Review published early Online and in an upcoming edition of The Lancet. |
|
Research on the effectiveness of a major class of drug - statins, used to reduce cholesterol - has come under the spotlight in a new article
published in PLoS Medicine. There are several statins now on the market and many research trials have compar |
|
Researchers have shown that key chemicals that carry cholesterol and fats in the blood accumulate in people with type 2 diabetes, which may help improve treatment of this disease.
|
|
Researchers have found that one of the reasons people with low HDL - a molecule that helps eliminate excess cholesterol from arteries - are at risk of developing heart disease could be a defective version of a protein called ABCA1.
|
INFO
